First line treatment selection modifies disease course and long-term clinical outcomes in Mycobacterium avium complex pulmonary disease

The combination of rifamycin (RFP), ethambutol (EB), and macrolides is currently the standard regimen for treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). However, poor adherence to the standardized regimens recommended by current guidelines have been reported. We undertook a sin...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Fukushima, Kiyoharu, Kitada, Seigo, Komukai, Sho, Kuge, Tomoki, Matsuki, Takanori, Kagawa, Hiroyuki, Tsujino, Kazuyuki, Miki, Mari, Miki, Keisuke, Kida, Hiroshi
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807086/
https://ncbi.nlm.nih.gov/pubmed/33441977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-021-81025-w
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky